latest news stock values companies glp-1 obesity cardiometabolic A new Science Perspective highlights the growing body of evidence that hints at the potential of GLP-1–based medications in treating conditions other than diabetes and obesity, including cardiovascular disease and neurodegenerative disorders Didn't take much for the

The Food Institute Podcast How can a food industry trade show spark global culinary creativity

You would think that the younger generations, Millennials and Generation Z, wouldn't be as concerned, Millennials and Generation Z, wouldn't be as concerned [with GLP-1 coverage] as our Boomers and Xers

supplements typically lack rigorous human studies Standardization : Medications contain precise, consistent doses

The availability of oral formulations addresses patient preferences for non-injectable medications while the entry of additional manufacturers beyond the current duopoly is expected to improve supply availability and create pricing competition that will facilitate broader access

Together, they mimic GLP-1s metabolic benefits, helping you maintain weight loss after GLP-1 without feeling overwhelmed

Patients using an outside lab, pharmacy, or service should confirm whether additional charges apply